Skip to main content
Dupilumab offers ‘clinically meaningful’ improvements in prurigo nodularis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Dupilumab offers ‘clinically meaningful’ improvements in prurigo nodularis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Pruritus
0
0.62
Atopy
0
0.52
Europe
0
0.31
Biologic Therapy
0
0.29
Quality of Life
0
0.21
Skin Lesion
0
0.21
Anxiety Disorder
0
0.15
Cornea and External Disease
0
0.15
Depression
0
0.15
Pain Management
0
0.15
Anxiety
0
0.1
Atopic Dermatitis
0
0.1
Calcineurin Inhibitor
0
0.1
Conjunctivitis
0
0.1
Hospital
0
0.1
Immunosuppressive Therapy
0
0.1
Interleukin
0
0.1
Monoclonal Antibody
0
0.1
Neuromodulators
0
0.1
Pain
0
0.1
Patient History
0
0.1
Phototherapy
0
0.1
Preventive Screening
0
0.1
Prurigo Nodularis
0
0.99
Receptors
0
0.1
Steroids
0
0.1
Topical Medication
0
0.1
Ultraviolet Light
0
0.1
Viral Infection
0
0.1
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
0.7
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Pharmacist
0
0.6
Edit Tags